Contributing Member of the Healthcare Councils

GLG News by this Author

Innovation in Pharmaceutical Product Marketing

June 22, 2009

Analysis of:Genentech's Cloud Cover | www.businessweek.com

1. Instant access to company experts reinforces a company commitment to patients not profits 2.When a physician needs a question answered , an immediate response is required, Genetech's approach offers this solution.

Great drug fot the wrong economic time

June 15, 2009

Analysis of:Bausch and Lomb (BOL) Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') | www.lifescience-online.com

1. This agent offers a decided advantage in presentation of an antibiotic.2. Chief therapeutic advantage is in the therapy of marginal blepharitis3. In these economic times, tends are to generics and in the case of self limited bacterial infections, no therapy at all.

Reconcilation: A Roadway to Mangled Healthcare Reform Legislation

April 27, 2009

Analysis of:Reconciliation: This Changes Everything | blogs.tnr

1. Because of the criteria needed to enact reconciliation,known as the Byrd rule, reconciliation may never be an integral part of health care legislation. If reconciliation is used important debate and discussion regarding the wisdom of substantial policy reform will never take place. 2. Health care  reform will impact each and every facet of the health care industry. 3. Companies that would benefit from reform  are vendors of electronic data storage, web platforms for providing medical records, electronic medical records and service industries  that successfully manage outcomes. Pharmaceutical and medical equipment suppliers will suffer severely and health insures may be entirely out of business.

Jet Lag a Forme Fruste of Shift Work Insomnia

April 23, 2009

Analysis of:Cephalon to apply for FDA approval for Nuvigil for jet lag | www.reuters.com

1.Shift work insomnia, an approved indication for provigil, is both vastly underdiagnosed and under treated. Jet lag is indeed a forme fruste of this condition 2. Currently available techniques for coping with Jet lag are either ineffective ( such as over the counter stimulants and sedatives) or onerous,( chronotherapy involving shifting bedtime). 3. Nuvigil a superb agent with low risk for abuse should be approved for jet lag dyssomnia, and should expand its market vastly.

Kudos to the FDA!

September 7, 2007

Analysis of:FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product | www.medicalnewstoday.com

The web based marketing of cyber snake oil is of concern to practitioners of medicine in every venue. Although there are many products have failed to pass sucessfully through the FDA process, this compound among others hallmarks a federal agency's ability to prevent sale of a possible useless or dangerous product. Nutraceuticals, herbals and homeopathy need to be validated in the same manner requisite of other pharmaceuticals prior to sale or distribution. Perhaps the Federal govt via the FDA, could subsidize well designed RCT studies of these common and generically available agents Stephen L Newman MD, MBA, FACP

Interesting but not practically relevant

November 9, 2006

Analysis of:CHEST: Statins May Retard Lung Deterioration in Smokers | www.medpagetoday.com

1. Statins are an unusual class of pharmaceutics that have a wide range of action beyond lipid management
2. Almost all current smokers place themselves at risk for coronary artery disease and have a high prevalence of hyperlipidemia
3. Physicians will not likely prescribe statins for lung remodeling

Relevance in the intensive care unit and perioperative therapy

November 9, 2006

Analysis of:Northfield Laboratories, Inc. Reports First Quarter Fiscal 2007 Financial Results | phx.corporate-ir.net

1. This product could very well revolutionize the delivery of oxygen to the plethora of organ systems under duress in both perioperative periods as well as in critically ill individuals.

2. Decisions to delay blood transfusion for fear of transfusion reaction could probably be laid to rest as long as blood viscosity does not increase.

Page : 11 to 7 of 7